📊 HTFL Key Takeaways
Is HTFL a Good Investment? Thesis Analysis
HeartFlow demonstrates strong fundamentals in revenue growth (39.9% YoY) and exceptional gross margins (76.8%), indicating solid product-market fit in the medical device sector. However, severe operating losses (-$36.4% margin), significant cash burn (-$59M FCF), and less than one year of cash runway present material execution risk and likely require near-term profitability progress or capital raise.
Why Buy HTFL? Key Strengths
- Strong revenue growth of 39.9% YoY ($176M) demonstrates robust market demand and adoption
- Exceptional gross margin of 76.8% indicates strong product economics, pricing power, and operational efficiency
- Fortress balance sheet with zero debt, $300.6M stockholders equity, $44.8M cash, and excellent liquidity (5.20x current ratio)
HTFL Investment Risks to Consider
- Critical cash burn of -$59M annually (FCF margin -33.5%) with approximately 9 months of runway at current burn rate
- Severe unprofitability with -$116.8M net loss and -$36.4% operating margin despite strong gross margins, indicating unsustainable OpEx structure
- Must achieve profitability or raise capital soon; dilution risk or forced cost restructuring could impair shareholder value
Key Metrics to Watch
- Operating expense ratio trend relative to revenue growth and path to operating profitability
- Free cash flow inflection point and monthly cash burn rate
- Gross margin sustainability and revenue growth deceleration at scale
HTFL Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 5.20x current ratio provides a solid financial cushion.
HTFL Profitability Ratios
HTFL vs Healthcare Sector
How Heartflow, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is HTFL Overvalued or Undervalued?
Based on fundamental analysis, Heartflow, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
HTFL Balance Sheet & Liquidity
HTFL 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Heartflow, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-25.32 indicates the company is currently unprofitable.
HTFL Growth Metrics (YoY)
HTFL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $32.9M | -$9.2M | $-1.04 |
| Q2 2025 | $31.1M | -$9.2M | $-1.46 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
HTFL Capital Allocation
HTFL SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Heartflow, Inc. (CIK: 0001464521)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HTFL
What is the AI rating for HTFL?
Heartflow, Inc. (HTFL) has an AI rating of HOLD with 55% confidence, based on fundamental analysis of SEC EDGAR filings.
What are HTFL's key strengths?
Claude: Strong revenue growth of 39.9% YoY ($176M) demonstrates robust market demand and adoption. Exceptional gross margin of 76.8% indicates strong product economics, pricing power, and operational efficiency.
What are the risks of investing in HTFL?
Claude: Critical cash burn of -$59M annually (FCF margin -33.5%) with approximately 9 months of runway at current burn rate. Severe unprofitability with -$116.8M net loss and -$36.4% operating margin despite strong gross margins, indicating unsustainable OpEx structure.
What is HTFL's revenue and growth?
Heartflow, Inc. reported revenue of $176.0M.
Does HTFL pay dividends?
Heartflow, Inc. does not currently pay dividends.
Where can I find HTFL SEC filings?
Official SEC filings for Heartflow, Inc. (CIK: 0001464521) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HTFL's EPS?
Heartflow, Inc. has a diluted EPS of $-3.17.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is HTFL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Heartflow, Inc. has a HOLD rating with 55% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is HTFL stock overvalued or undervalued?
Valuation metrics for HTFL: ROE of -38.8% (sector avg: 15%), net margin of -66.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy HTFL stock in 2026?
Our dual AI analysis gives Heartflow, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is HTFL's free cash flow?
Heartflow, Inc.'s operating cash flow is $-54.0M, with capital expenditures of $5.0M. FCF margin is -33.5%.
How does HTFL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -66.3% (avg: 12%), ROE -38.8% (avg: 15%), current ratio 5.20 (avg: 2).